ICCC Stock Analysis: Buy, Sell, or Hold?

ICCC - Immucell Corp

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$10.29
-0.71 (-6.45%) ▼
5d: +4.04%
30d: +5.11%
90d: +62.05%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026

Get Alerted When ICCC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ICCC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: ICCC is currently trading at $10.29, which is considered extended relative to its 30-day fair value range of $9.52 to $10.25.

Technical Outlook: Technically, ICCC is in a strong uptrend. Immediate support is located at $9.29, while resistance sits at $10.75. Short-term momentum is weak, with the stock down 6.5% recently.

Market Sentiment: ICCC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.00 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $9.52 - $10.25
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.5%)
  • BULLISH: Trading 36.1% below Wall St target ($14.00)

Trading Range Analysis

30-Day Trading Range $9.52 - $10.25
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $9.29
Resistance Level $10.75
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Wall Street Target $14.00 (+36.1%)
Revenue Growth (YoY) 28.4%
Earnings Growth (YoY) 31.3%
Profit Margin -1.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 10:41 PM ET
Data refreshes hourly during market hours. Next update: 11:41 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ICCC.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$257 61 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 58 HOLD
BEAM
Beam Therapeutics Inc
STRONG BUY
17 analysts
$51 62 BUY
IMCR
Immunocore Holdings Ltd
STRONG BUY
17 analysts
$63 64 BUY
TVTX
Travere Therapeutics Inc
STRONG BUY
15 analysts
$58 61 BUY

More Analysis for ICCC

ICCC Technical Chart ICCC Price Prediction ICCC Earnings Date ICCC Investment Advisor ICCC Fair Price Analyzer ICCC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals